Drug profile · INN
propoxyphene napsylate
DARVON-N
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
propoxyphene napsylate (DARVON-N) is an FDA-listed pharmaceutical active ingredient. Associated with Dyne Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN propoxyphene napsylate
Brand DARVON-N
Route ORAL
Formulation TABLET
Originator Dyne Therapeutics
Frequently asked questions
What is propoxyphene napsylate?
propoxyphene napsylate (DARVON-N) is an FDA-listed pharmaceutical active ingredient. Associated with Dyne Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for propoxyphene napsylate?
DARVON-N is a marketed brand name for propoxyphene napsylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propoxyphene napsylate?
propoxyphene napsylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.